check_circleStudy Completed

Cystic Fibrosis

Pilot study to compare acarbose (BAY g 5421) with placebo in respect of efficacy and tolerability in patients with cystic fibrosis and pathological glucose tolerance

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

7 - 25 Years
  • -

  • -

Trial summary

Enrollment Goal
12
Trial Dates
November 1993 - September 1995
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Acarbose (Precose/Glucobay, BAYG5421)
Accepts Healthy Volunteer
N/A

Trial design

Double-blind, cross-over clinical study at a single centre to compare acarbose (BAY g 5421) with placebo in respect of efficacy and tolerability in patients with cystic fibrosis and pathological glucose tolerance (pilot study).
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A